The COVID pandemic illustrated how urgently we need antiviral medications capable of treating coronavirus infections.

COVID is still with us, and there will be other pandemics. It’s critical that we don’t forget the lessons we’ve learned.” ...

A promising path to fighting COVID and other coronaviruses may have been based on a serious mistake. Scientists had zeroed in ...

So when the open-source foundation model DeepSeek-R1 suddenly outperformed many global peers, it struck a nerve. This launch ...

A contagious new COVID-19 variant called NB.1.8.1, aka "Nimbus," is now dominant in the United States, CDC data show. What to know about symptoms and vaccines.

When the first reports of a new COVID-19 variant emerge, scientists worldwide scramble to answer a critical question: Will ...

The COVID pandemic illustrated how urgently we need antiviral medications capable of treating coronavirus infections. To aid ...

SARS-CoV-2 infection in children and adolescents increases risk for cardiovascular disease, compared with uninfected individuals.

The Business Research Company's The Specific Antiviral Drugs For COVID 19 Market Forecast To 2034 – For Business Leaders, Analysts, And Strategic Teams It will grow to $28.43 billion in 2029 at a ...

Creating a Promising and Novel Molecule In their research, Professor Gauthier's team studied two natural molecules: betulinic ...

FDA vaccines chief Vinay Prasad limited broader use of COVID vaccines, citing reduced risk and data concerns. Read more here.